Latest close: a new 52-week lowSep 8, 2026what changed →2024-08-15$23.38 – $49.84 · dashed line: 200-day average2026-09-08
On our screens:Cheap stocks by free cash flow yield
What is the market doing?
What the tape says about COLL
Collegium Pharmaceutical, Inc. is −39% over the past year while the S&P 500 is +20%: 59 points behind the market.
−39%
1-year return · S&P 500 +20%
- vs 200-day average
- −39%
vs 200-day average · a clear downtrend
- RSI (14)
- 18
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 53%
Below its 52-week high
Details›
- Last close2026-09-08
- $23.38
- 1 monthS&P 500 −0.30%
- −20%
- 1 yearS&P 500 +20%
- −39%
- 5 yearsS&P 500 +85%
- +25%
- vs 50-day average$31.35
- −25%
- 52-week high
- $49.84
- 52-week low
- $23.38
- Annualised volatility
- 42%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$629K
| Year | Return |
|---|---|
| 2026 (year to date) | −50% |
| 2025 | +62% |
| 2024 | −6.9% |
| 2023 | +33% |
| 2022 | +24% |
| 2021 | −6.7% |
| 2020 | −2.7% |
| 2019 | +20% |
| 2018 | −7.0% |
| 2017 | +19% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +8.4% |
| Feb | 10 | 5 of 10 | +0.12% |
| Mar | 10 | 5 of 10 | −7.9% |
| Apr | 10 | 2 of 10 | −3.4% |
| May | 10 | 3 of 10 | −3.5% |
| Jun | 10 | 6 of 10 | +6.3% |
| Jul | 11 | 6 of 11 | −1.4% |
| Aug | 11 | 5 of 11 | −4.2% |
| Sep | 11 | 4 of 11 | +9.0% |
| Oct | 10 | 4 of 10 | −2.5% |
| Nov | 10 | 8 of 10 | +23% |
| Dec | 10 | 5 of 10 | +1.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #16 of 29 by Smart Score